Abstract

Background: Adnexal masses can be of varied etiology. It may be benign like luteal cyst, infective likeabscess or malignant like ovarian cancer. These masses are detected on pelvic or abdominal examinationand sometimes incidentally found on ultrasonographic evaluation. Adnexal masses manifests with a widespectrum of clinical, morphological and histological features. Cancer Antigen 125 is a marker in the bloodthat is known to be elevated in women with ovarian cancer, but also in people with other medical conditionsand in some healthy people. This biomarker can be useful when an ovarian mass is felt on examination orseen on ultrasound and the physician is unsure whether it is ovarian cancer. The Aims and Objectives was tostudy the diagnostic value of Cancer Antigen 125 in adnexal masses, the correlation of this tumour markerwith type of adnexal masses.Material and Method: Fifty patients from reproductive to postmenopausal age group meeting the inclusionand exclusion criteria with adnexal mass were taken. Thorough history taking, clinical examination,laboratory investigation including CA 125 and histopathological evaluation was done.Results: The mean age was found to be 42.3 ± 11.1 years. Of fifty cases 80% were benign and 20% weremalignant in histopathology. Maximum number of cases (54%) were with parity between 1-3. Clinicalpresentation had no clear predictive value in malignant or benign nature of the mass. In our study CA125 hasa sensitivity of 90% and specificity of 35% . Positive predictive value was 25.71% and negative predictivevalue of 93.3%.Conclusion: The detection of pelvic mass with an associated elevated CA 125 is highly suspicious of ovariancancer, but there are various benign conditions which mimic the above findings, especially in premenopausalwomen.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call